Kalvista Pharmaceuticals Inc (KALV) is up 0.35% in a Week, Should You Hold?

A rating of 94 puts Kalvista Pharmaceuticals Inc (KALV) near the top of the Biotechnology industry according to InvestorsObserver. Kalvista Pharmaceuticals Inc's score of 94 means it scores higher than 94% of stocks in the industry. Kalvista Pharmaceuticals Inc also received an overall rating of 78, putting it above 78% of all stocks. Biotechnology is ranked 58 out of the 148 industries.

KALV has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on KALV!

See Full KALV Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 78 means the stock is more attractive than 78 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Kalvista Pharmaceuticals Inc Stock Today?

Kalvista Pharmaceuticals Inc (KALV) stock is trading at $8.53 as of 11:42 AM on Tuesday, Oct 31, a gain of $0.51, or 6.36% from the previous closing price of $8.02. The stock has traded between $7.99 and $8.57 so far today. Volume today is low. So far 56,883 shares have traded compared to average volume of 308,901 shares. Click Here to get the full Stock Report for Kalvista Pharmaceuticals Inc stock.